Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17104ExperimentalSmall molecule
BG-P400-TAT: Overview.
- Formula / weight
- C39H48I4N6O11 · 1284.462 g/mol (avg)
- Also known as
- [4-(4-{1-[2-(2-{2-[2-(2-{2-[2-(4-guanidinomethyl-phenoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethyl]-1H-[1,2,3]triazol-4-ylmethoxy}-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-acetic acid · 2-[4-[4-[[1-[2-[2-[2-[2-[2-[2-[2-[4-[(Diaminomethylideneamino)methyl]phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methoxy]-3,5-diiodophenoxy]-3,5-diiodophenyl]acetic acid
- Code names
- BG-P400-TAT
Resolves to
Structure
InChIKey
DVWARFPIVDNTDK-UHFFFAOYSA-NSMILESNC(=N)NCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCN2C=C(COC3=C(I)C=C(OC4=C(I)C=C(CC(O)=O)C=C4I)C=C3I)N=N2)C=C1Which companies are running trials of BG-P400-TAT, in which indications and phases, and which of those programs are still active?